1. Home
  2. CMCO vs CRVS Comparison

CMCO vs CRVS Comparison

Compare CMCO & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

HOLD

Current Price

$20.52

Market Cap

492.7M

Sector

Industrials

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$6.86

Market Cap

546.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCO
CRVS
Founded
1875
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.7M
546.7M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
CMCO
CRVS
Price
$20.52
$6.86
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$35.00
$13.75
AVG Volume (30 Days)
210.9K
1.6M
Earning Date
02-09-2026
11-04-2025
Dividend Yield
1.40%
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$977,994,000.00
N/A
Revenue This Year
$5.60
N/A
Revenue Next Year
$4.23
N/A
P/E Ratio
$152.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.78
$2.54
52 Week High
$37.81
$9.60

Technical Indicators

Market Signals
Indicator
CMCO
CRVS
Relative Strength Index (RSI) 75.15 40.76
Support Level $17.13 $6.39
Resistance Level $19.41 $7.18
Average True Range (ATR) 0.74 0.44
MACD 0.20 -0.05
Stochastic Oscillator 76.85 31.74

Price Performance

Historical Comparison
CMCO
CRVS

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: